CN117142916B - Preparation method of allyl sulfone compound - Google Patents
Preparation method of allyl sulfone compound Download PDFInfo
- Publication number
- CN117142916B CN117142916B CN202311105963.3A CN202311105963A CN117142916B CN 117142916 B CN117142916 B CN 117142916B CN 202311105963 A CN202311105963 A CN 202311105963A CN 117142916 B CN117142916 B CN 117142916B
- Authority
- CN
- China
- Prior art keywords
- acid
- propyl
- allyl alcohol
- sulfinic acid
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- -1 allyl sulfone compound Chemical class 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title abstract description 8
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 claims abstract description 64
- 238000006243 chemical reaction Methods 0.000 claims abstract description 28
- BUUPQKDIAURBJP-UHFFFAOYSA-N sulfinic acid Chemical compound OS=O BUUPQKDIAURBJP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000002904 solvent Substances 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 14
- 239000007810 chemical reaction solvent Substances 0.000 claims abstract description 12
- 125000001931 aliphatic group Chemical group 0.000 claims abstract description 6
- 239000012298 atmosphere Substances 0.000 claims abstract description 4
- 239000011261 inert gas Substances 0.000 claims abstract description 4
- 150000001335 aliphatic alkanes Chemical class 0.000 claims abstract description 3
- 125000004122 cyclic group Chemical group 0.000 claims abstract description 3
- 150000001924 cycloalkanes Chemical class 0.000 claims abstract description 3
- 238000000746 purification Methods 0.000 claims abstract description 3
- 238000003756 stirring Methods 0.000 claims abstract 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 33
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 21
- 238000004809 thin layer chromatography Methods 0.000 claims description 18
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 14
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 9
- 239000003208 petroleum Substances 0.000 claims description 7
- OOCCDEMITAIZTP-QPJJXVBHSA-N (E)-cinnamyl alcohol Chemical compound OC\C=C\C1=CC=CC=C1 OOCCDEMITAIZTP-QPJJXVBHSA-N 0.000 claims description 6
- GETTZEONDQJALK-UHFFFAOYSA-N (trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=CC=C1 GETTZEONDQJALK-UHFFFAOYSA-N 0.000 claims description 6
- JQDUHQARXQIRHF-HWKANZROSA-N (e)-3-(2-nitrophenyl)prop-2-en-1-ol Chemical compound OC\C=C\C1=CC=CC=C1[N+]([O-])=O JQDUHQARXQIRHF-HWKANZROSA-N 0.000 claims description 3
- VKSIYNNFGTVYJU-QPJJXVBHSA-N (e)-3-cyclohexylprop-2-en-1-ol Chemical compound OC\C=C\C1CCCCC1 VKSIYNNFGTVYJU-QPJJXVBHSA-N 0.000 claims description 3
- YVZWQPOTHRMEQW-UHFFFAOYSA-N 4-methoxybenzenesulfinic acid Chemical compound COC1=CC=C(S(O)=O)C=C1 YVZWQPOTHRMEQW-UHFFFAOYSA-N 0.000 claims description 3
- FXJVNINSOKCNJP-UHFFFAOYSA-N 4-methylbenzenesulfinic acid Chemical compound CC1=CC=C(S(O)=O)C=C1 FXJVNINSOKCNJP-UHFFFAOYSA-N 0.000 claims description 3
- VEWUTMSLGMROMK-VDESZNBCSA-N (2e,4e)-5-phenylpenta-2,4-dien-1-ol Chemical compound OC\C=C\C=C\C1=CC=CC=C1 VEWUTMSLGMROMK-VDESZNBCSA-N 0.000 claims description 2
- LLNAMUJRIZIXHF-VQHVLOKHSA-N (e)-2-methyl-3-phenylprop-2-en-1-ol Chemical compound OCC(/C)=C/C1=CC=CC=C1 LLNAMUJRIZIXHF-VQHVLOKHSA-N 0.000 claims description 2
- BJVFNYWWCGKVNR-OWOJBTEDSA-N (e)-3-(4-fluorophenyl)prop-2-en-1-ol Chemical compound OC\C=C\C1=CC=C(F)C=C1 BJVFNYWWCGKVNR-OWOJBTEDSA-N 0.000 claims description 2
- ZXMZAFMNGMMUFA-HNQUOIGGSA-N (e)-3-thiophen-2-ylprop-2-en-1-ol Chemical compound OC\C=C\C1=CC=CS1 ZXMZAFMNGMMUFA-HNQUOIGGSA-N 0.000 claims description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims description 2
- DAGLBEYRVSLOCL-UHFFFAOYSA-N 1h-indole-3-sulfinic acid Chemical compound C1=CC=C2C(S(=O)O)=CNC2=C1 DAGLBEYRVSLOCL-UHFFFAOYSA-N 0.000 claims description 2
- CGRMGOGJWHPCFJ-UHFFFAOYSA-N 2,4,6-trimethylbenzenesulfinic acid Chemical compound CC1=CC(C)=C(S(O)=O)C(C)=C1 CGRMGOGJWHPCFJ-UHFFFAOYSA-N 0.000 claims description 2
- BOJXVYVIGCXZJY-UHFFFAOYSA-N 2-nitrobenzenesulfinic acid Chemical compound OS(=O)C1=CC=CC=C1[N+]([O-])=O BOJXVYVIGCXZJY-UHFFFAOYSA-N 0.000 claims description 2
- IMMPLAUVBYOSBD-UHFFFAOYSA-N 3-methylbenzenesulfinic acid Chemical compound CC1=CC=CC(S(O)=O)=C1 IMMPLAUVBYOSBD-UHFFFAOYSA-N 0.000 claims description 2
- JIUIHDUXMVJNKD-UHFFFAOYSA-N 4-(trifluoromethyl)benzenesulfinic acid Chemical compound OS(=O)C1=CC=C(C(F)(F)F)C=C1 JIUIHDUXMVJNKD-UHFFFAOYSA-N 0.000 claims description 2
- ZIJWGEHOVHJHKB-BQYQJAHWSA-N 4-Phenyl-3-buten-2-ol Chemical compound CC(O)\C=C\C1=CC=CC=C1 ZIJWGEHOVHJHKB-BQYQJAHWSA-N 0.000 claims description 2
- AOQYAMDZQAEDLO-UHFFFAOYSA-N 4-chlorobenzenesulfinic acid Chemical compound OS(=O)C1=CC=C(Cl)C=C1 AOQYAMDZQAEDLO-UHFFFAOYSA-N 0.000 claims description 2
- SEEUPVOHHNMWEG-UHFFFAOYSA-N 4-fluorobenzenesulfinic acid Chemical compound OS(=O)C1=CC=C(F)C=C1 SEEUPVOHHNMWEG-UHFFFAOYSA-N 0.000 claims description 2
- JLHJMAPTGYSCRN-UHFFFAOYSA-N 4-tert-butylbenzenesulfinic acid Chemical compound CC(C)(C)C1=CC=C(S(O)=O)C=C1 JLHJMAPTGYSCRN-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- BXPMVQYOXKZTOA-UHFFFAOYSA-N anthracene-9-sulfinic acid Chemical compound C1=CC=C2C(S(=O)O)=C(C=CC=C3)C3=CC2=C1 BXPMVQYOXKZTOA-UHFFFAOYSA-N 0.000 claims description 2
- NVSONFIVLCXXDH-UHFFFAOYSA-N benzylsulfinic acid Chemical compound O[S@@](=O)CC1=CC=CC=C1 NVSONFIVLCXXDH-UHFFFAOYSA-N 0.000 claims description 2
- DCBILZQETXFXAY-UHFFFAOYSA-N butane-1-sulfinic acid Chemical compound CCCCS(O)=O DCBILZQETXFXAY-UHFFFAOYSA-N 0.000 claims description 2
- SJNAEBWOVPMUKS-UHFFFAOYSA-N cyclopropanesulfinic acid Chemical compound OS(=O)C1CC1 SJNAEBWOVPMUKS-UHFFFAOYSA-N 0.000 claims description 2
- RQIFXTOWUNAUJC-UHFFFAOYSA-N ethanesulfinic acid Chemical compound CCS(O)=O RQIFXTOWUNAUJC-UHFFFAOYSA-N 0.000 claims description 2
- DCPSBASPZDPTFL-UHFFFAOYSA-N furan-2-sulfinic acid Chemical compound OS(=O)C1=CC=CO1 DCPSBASPZDPTFL-UHFFFAOYSA-N 0.000 claims description 2
- XNEFVTBPCXGIRX-UHFFFAOYSA-N methanesulfinic acid Chemical compound CS(O)=O XNEFVTBPCXGIRX-UHFFFAOYSA-N 0.000 claims description 2
- LTSBKUWFXANFCU-UHFFFAOYSA-N naphthalene-2-sulfinic acid Chemical compound C1=CC=CC2=CC(S(=O)O)=CC=C21 LTSBKUWFXANFCU-UHFFFAOYSA-N 0.000 claims description 2
- PTYNSKRKVPMPAX-UHFFFAOYSA-N pyridine-2-sulfinic acid Chemical compound OS(=O)C1=CC=CC=N1 PTYNSKRKVPMPAX-UHFFFAOYSA-N 0.000 claims description 2
- AUPDIWFBUOVUGO-UHFFFAOYSA-N thiophene-2-sulfinic acid Chemical compound OS(=O)C1=CC=CS1 AUPDIWFBUOVUGO-UHFFFAOYSA-N 0.000 claims description 2
- SFEBPWPPVGRFOA-UHFFFAOYSA-N trifluoromethanesulfinic acid Chemical compound OS(=O)C(F)(F)F SFEBPWPPVGRFOA-UHFFFAOYSA-N 0.000 claims description 2
- LGXXEDSIJZHDBN-OWOJBTEDSA-N (e)-3-(4-nitrophenyl)prop-2-en-1-ol Chemical compound OC\C=C\C1=CC=C([N+]([O-])=O)C=C1 LGXXEDSIJZHDBN-OWOJBTEDSA-N 0.000 claims 1
- NZEDMAWEJPYWCD-UHFFFAOYSA-N 3-prop-2-enylsulfonylprop-1-ene Chemical class C=CCS(=O)(=O)CC=C NZEDMAWEJPYWCD-UHFFFAOYSA-N 0.000 abstract description 8
- 239000000758 substrate Substances 0.000 abstract description 4
- 239000003446 ligand Substances 0.000 abstract description 3
- 239000003054 catalyst Substances 0.000 abstract description 2
- 230000007613 environmental effect Effects 0.000 abstract description 2
- 238000009776 industrial production Methods 0.000 abstract description 2
- 239000012295 chemical reaction liquid Substances 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical group C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 10
- 238000005481 NMR spectroscopy Methods 0.000 description 9
- JEHKKBHWRAXMCH-UHFFFAOYSA-N benzenesulfinic acid Chemical compound O[S@@](=O)C1=CC=CC=C1 JEHKKBHWRAXMCH-UHFFFAOYSA-N 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 7
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 5
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 5
- 125000000217 alkyl group Chemical group 0.000 description 5
- 238000012512 characterization method Methods 0.000 description 5
- 229940126214 compound 3 Drugs 0.000 description 5
- 229940125898 compound 5 Drugs 0.000 description 5
- 239000012299 nitrogen atmosphere Substances 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 4
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 238000006880 cross-coupling reaction Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 125000001072 heteroaryl group Chemical group 0.000 description 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229910052723 transition metal Inorganic materials 0.000 description 2
- 150000003624 transition metals Chemical class 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- LCGZHXVOTKRCAL-HNQUOIGGSA-N (e)-3-(furan-2-yl)prop-2-en-1-ol Chemical compound OC\C=C\C1=CC=CO1 LCGZHXVOTKRCAL-HNQUOIGGSA-N 0.000 description 1
- YQJJXNLVPNKFCQ-UHFFFAOYSA-N 1-methyl-4-(3-phenylprop-2-enylsulfonyl)benzene Chemical compound C1=CC(C)=CC=C1S(=O)(=O)CC=CC1=CC=CC=C1 YQJJXNLVPNKFCQ-UHFFFAOYSA-N 0.000 description 1
- WCASXYBKJHWFMY-NSCUHMNNSA-N 2-Buten-1-ol Chemical compound C\C=C\CO WCASXYBKJHWFMY-NSCUHMNNSA-N 0.000 description 1
- 238000005712 Baylis-Hillman reaction Methods 0.000 description 1
- 229910014033 C-OH Inorganic materials 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001391944 Commicarpus scandens Species 0.000 description 1
- 229910014570 C—OH Inorganic materials 0.000 description 1
- OIFBSDVPJOWBCH-UHFFFAOYSA-N Diethyl carbonate Chemical compound CCOC(=O)OCC OIFBSDVPJOWBCH-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 1
- 101001121408 Homo sapiens L-amino-acid oxidase Proteins 0.000 description 1
- 101000827703 Homo sapiens Polyphosphoinositide phosphatase Proteins 0.000 description 1
- 102100026388 L-amino-acid oxidase Human genes 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- 102100023591 Polyphosphoinositide phosphatase Human genes 0.000 description 1
- 101100012902 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FIG2 gene Proteins 0.000 description 1
- 101100233916 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KAR5 gene Proteins 0.000 description 1
- AWOQCRQDXFVJPL-JXMROGBWSA-N [(e)-3-(benzenesulfonyl)prop-1-enyl]benzene Chemical compound C=1C=CC=CC=1S(=O)(=O)C\C=C\C1=CC=CC=C1 AWOQCRQDXFVJPL-JXMROGBWSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000004808 allyl alcohols Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000002852 cysteine proteinase inhibitor Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- IEJIGPNLZYLLBP-UHFFFAOYSA-N dimethyl carbonate Chemical compound COC(=O)OC IEJIGPNLZYLLBP-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000006277 sulfonation reaction Methods 0.000 description 1
- 125000001174 sulfone group Chemical group 0.000 description 1
- 150000003457 sulfones Chemical group 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B45/00—Formation or introduction of functional groups containing sulfur
- C07B45/04—Formation or introduction of functional groups containing sulfur of sulfonyl or sulfinyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C315/00—Preparation of sulfones; Preparation of sulfoxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
技术领域Technical Field
本发明属于有机化学合成技术领域,尤其涉及一种烯丙基砜类化合物的制备方法。The invention belongs to the technical field of organic chemical synthesis, and in particular relates to a method for preparing an allyl sulfone compound.
背景技术Background Art
烯丙基砜类化合物广泛存在于天然产物中,且普遍存在于药物分子、功能材料中,例如抗异常细胞增殖药物,半胱氨酸蛋白酶抑制剂,促甲状腺受体拮抗剂以及抗菌剂中。又由于其本身含有烯丙基和砜基团,也可作为化学合成中的多用途构建基。Allyl sulfone compounds are widely present in natural products and are commonly found in drug molecules and functional materials, such as anti-abnormal cell proliferation drugs, cysteine protease inhibitors, thyroid-stimulating receptor antagonists and antibacterial agents. Because they contain allyl and sulfone groups, they can also be used as multi-purpose building blocks in chemical synthesis.
考虑到烯丙基砜的广泛应用价值,人们开发了各种方法来有效地构建该官能团骨架。最传统的方法一般是过渡金属催化下利用功能化的烯丙基化合物和活性磺酰前体进行交叉偶联反应来制备,但这些反应都会产生不同化学计量的有害副产物,原子经济性较低。随着研究的发展,人们发现,醇是比较丰富的资源,自然界中存在广泛,且价廉易得、环境友好,构筑烯丙基骨架最理想的方式是直接利用烯丙醇与磺酰前体进行脱水交叉偶联反应进行制备。但是众所周知,C-OH键具有较高活化势垒,不易断裂,为了克服这一难点,研究人员提出了不同的解决策略,比如加入三乙胺、氢氧化硼、三甲基氯硅烷等添加剂来达到这一目的,但是当加入酸性添加剂时,只有芳香磺酰基与此反应相容,大大限制了底物的范围且反应高度依赖于添加剂的选择,同时其也需要较高的过渡金属催化当量,较高的反应温度和有效的配体,成本较高。Considering the wide application value of allyl sulfone, people have developed various methods to effectively construct the functional group skeleton. The most traditional method is generally to prepare it by cross-coupling reaction of functionalized allyl compounds and active sulfonyl precursors under transition metal catalysis, but these reactions will produce harmful byproducts of different stoichiometric amounts and have low atom economy. With the development of research, people have found that alcohol is a relatively abundant resource, widely present in nature, cheap, easy to obtain, and environmentally friendly. The most ideal way to construct the allyl skeleton is to directly use allyl alcohol and sulfonyl precursors for dehydration cross-coupling reaction. However, it is well known that the C-OH bond has a high activation barrier and is not easy to break. In order to overcome this difficulty, researchers have proposed different solutions, such as adding triethylamine, boron hydroxide, trimethylsilyl chloride and other additives to achieve this goal. However, when acidic additives are added, only aromatic sulfonyl groups are compatible with this reaction, which greatly limits the scope of the substrate and the reaction is highly dependent on the choice of additives. At the same time, it also requires a higher transition metal catalytic equivalent, a higher reaction temperature and an effective ligand, and the cost is high.
随着研究的不断发展,一种水促进烯丙基砜的合成策略(NatureCommunications.,2018,9,1321.)实现了在水相中室温下以活泼烯丙醇为原料来高效制备烯丙基砜化合物,但是这一策略仅适用于高度活泼的烯丙醇(Morita-Baylis-Hillman醇和1,3-二芳基烯丙醇)。为了解决烯丙醇直接磺化制备烯丙基砜烯面临的底物的严重受限问题,后续有钯和钙共催化体系被开发(CN110627693 A),在室温环境下通过相互活化策略能够高效的完成以非活泼烯丙醇为原料的烯丙基砜骨架的构筑,然而重金属的参与导致成本骤然增加。With the continuous development of research, a water-promoted synthesis strategy for allyl sulfone (Nature Communications., 2018, 9, 1321.) has achieved the efficient preparation of allyl sulfone compounds using active allyl alcohol as raw material in water phase at room temperature, but this strategy is only applicable to highly active allyl alcohols (Morita-Baylis-Hillman alcohols and 1,3-diaryl allyl alcohols). In order to solve the serious limitation of substrates faced by direct sulfonation of allyl alcohol to prepare allyl sulfone olefins, a palladium and calcium co-catalytic system was subsequently developed (CN110627693 A). The mutual activation strategy can efficiently complete the construction of the allyl sulfone skeleton using inactive allyl alcohol as raw material at room temperature. However, the involvement of heavy metals leads to a sudden increase in costs.
发明内容Summary of the invention
本发明的目的在于提供一种烯丙基砜类化合物的制备方法。The object of the present invention is to provide a method for preparing allyl sulfone compounds.
本发明是这样实现的,一种烯丙基砜类化合物的制备方法,该方法包括以下步骤:The present invention is achieved by a method for preparing an allyl sulfone compound, the method comprising the following steps:
(1)在惰性气体氛围下,将亚磺酸和烯丙醇加入到反应溶剂中,在20~60℃温度下搅拌反应8~36h;其中,(1) Under an inert gas atmosphere, sulfinic acid and allyl alcohol are added to a reaction solvent, and the mixture is stirred at 20 to 60° C. for 8 to 36 hours; wherein:
所述亚磺酸选自正芳基亚磺酸、杂芳基亚磺酸、稠环亚磺酸、直链式脂肪亚磺酸、环式脂肪亚磺酸中的任意一种;The sulfinic acid is selected from any one of normal aryl sulfinic acid, heteroaryl sulfinic acid, condensed ring sulfinic acid, straight chain aliphatic sulfinic acid and cyclic aliphatic sulfinic acid;
所述烯丙醇选自正芳基烯丙醇、杂芳基烯丙醇、稠环烯丙醇、直链式烷烃烯丙醇、环式烷烃烯丙醇中的任意一种;The allyl alcohol is selected from any one of normal aryl allyl alcohol, heteroaryl allyl alcohol, condensed ring allyl alcohol, linear alkane allyl alcohol, and cyclic alkane allyl alcohol;
所述反应溶剂选自四氢呋喃、乙二醇二甲醚、甲苯、二甲基亚砜、丙酮、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、二氯甲烷、二氯乙烷、碳酸二甲酯、碳酸二乙酯中的任意一种;The reaction solvent is selected from any one of tetrahydrofuran, ethylene glycol dimethyl ether, toluene, dimethyl sulfoxide, acetone, N,N-dimethylformamide, N,N-dimethylacetamide, dichloromethane, dichloroethane, dimethyl carbonate and diethyl carbonate;
(2)TLC监测反应完全后,将步骤(1)所得反应液除去溶剂、纯化,得到烯丙基砜类化合物。(2) After the reaction is complete as monitored by TLC, the reaction solution obtained in step (1) is freed of solvent and purified to obtain an allyl sulfone compound.
优选地,在步骤(1)中,所述亚磺酸、烯丙醇、反应溶剂的摩尔体积比为0.9~18mmol:0.3~9mmol:2~4mL。Preferably, in step (1), the molar volume ratio of the sulfinic acid, allyl alcohol and reaction solvent is 0.9-18 mmol: 0.3-9 mmol: 2-4 mL.
优选地,在步骤(1)中,所述亚磺酸选自4-甲基苯亚磺酸、4-甲氧基苯亚磺酸、2-硝基苯亚磺酸、三氟甲基亚磺酸、4-氟苯亚磺酸、4-(三氟甲基)苯亚磺酸、苄基亚磺酸、2,4,6-三甲基苯亚磺酸、4-氯苯亚磺酸、4-(叔丁基)苯亚磺酸、2-萘基-亚磺酸、9-蒽基-亚磺酸3-甲基苯亚磺酸、噻吩-2-亚磺酸、呋喃-2-亚磺酸、吡啶-2-亚磺酸、吲哚-3-亚磺酸、乙基亚磺酸、丁基亚磺酸、甲基亚磺酸、环丙烷亚磺酸、右旋樟脑亚磺酸中的任意一种。Preferably, in step (1), the sulfinic acid is selected from any one of 4-methylbenzenesulfinic acid, 4-methoxybenzenesulfinic acid, 2-nitrobenzenesulfinic acid, trifluoromethylsulfinic acid, 4-fluorobenzenesulfinic acid, 4-(trifluoromethyl)benzenesulfinic acid, benzylsulfinic acid, 2,4,6-trimethylbenzenesulfinic acid, 4-chlorobenzenesulfinic acid, 4-(tert-butyl)benzenesulfinic acid, 2-naphthylsulfinic acid, 9-anthrylsulfinic acid, 3-methylbenzenesulfinic acid, thiophene-2-sulfinic acid, furan-2-sulfinic acid, pyridine-2-sulfinic acid, indole-3-sulfinic acid, ethylsulfinic acid, butylsulfinic acid, methylsulfinic acid, cyclopropanesulfinic acid and dextrorotatory camphorsulfinic acid.
优选地,在步骤(1)中,所述烯丙醇选自(E)-3-苯基丙-2-烯-1-醇、(E)-3-(4-氟苯基)丙-2-烯-1-醇、(E)-3-(3-氟苯基)丙基-2-烯-1-醇、(E)-3-(4-(三氟甲基)苯基)丙基-2-烯-1-醇、(E)-3-(4-溴苯基)丙基-2-烯-1-醇、(E)-3-(4-甲氧基苯基)丙基-2-烯-1-醇、(E)-3-(4-硝基苯基)丙-2-烯-1-醇、(E)-3-(2-硝基苯基)丙-2-烯-1-醇、(E)-3-(噻吩-2-基)丙-2-烯-1-醇、(E)-3-(吡啶-3-基)丙基-2-烯-1-醇、(E)-3-(呋喃-2-基)丙-2-烯-1-醇、(E)-3-(吲哚-2-基)丙-2-烯-1-醇、(E)-3-(4-(叔丁基)苯基)丙基-2-烯-1-醇、(E)-3-(3,5-二甲基苯基)丙基-2-烯-1-醇、1-(萘-2-基)丙基-2-烯-1-醇、1-(蒽-2-基)丙基-2-烯-1-醇(E)-3-(4-((三甲基硅基)乙炔基)苯基)丙基-2-烯-1-醇、(E)-5,9-二甲基癸-2,8-二烯-1-醇、(E)-3-(3-苯氧基苯基)丙基-2-烯-1-醇、(E)-2-溴丙烷-3-苯丙基-2-烯-1-醇、(E)-3-苯丁基-2-烯-1-醇、(E)-2-甲基-3-苯基丙-2-烯-1-醇、(E)-3-环己基丙-2-烯-1-醇、(E)-5,9-二甲基十-1,8-二烯-3-醇、(2E、4E)-5-苯基-2,4-戊二烯-1-醇、(E)-4-苯基-3-丁烯-2-醇、(E)-3-(2-甲氧基苯基)丙基-2-烯-1-醇、(E)-3-甲基丙-2-烯-1-醇中的任意一种。Preferably, in step (1), the allyl alcohol is selected from (E)-3-phenylprop-2-en-1-ol, (E)-3-(4-fluorophenyl)prop-2-en-1-ol, (E)-3-(3-fluorophenyl)propyl-2-en-1-ol, (E)-3-(4-(trifluoromethyl)phenyl)propyl-2-en-1-ol, (E)-3-(4-bromophenyl)propyl-2-en-1-ol, (E)-3-(4-methoxyphenyl)propyl-2-en-1-ol, (E)-3-(4-(trifluoromethyl)phenyl)propyl-2-en-1-ol (E)-3-(2-nitrophenyl)prop-2-en-1-ol, (E)-3-(2-nitrophenyl)prop-2-en-1-ol, (E)-3-(thiophen-2-yl)prop-2-en-1-ol, (E)-3-(pyridin-3-yl)propyl-2-en-1-ol, (E)-3-(furan-2-yl)prop-2-en-1-ol, (E)-3-(indol-2-yl)prop-2-en-1-ol, (E)-3-(4-(tert-butyl)phenyl)propyl-2-en-1-ol, (E)-3-(3 ,5-dimethylphenyl)propyl-2-en-1-ol, 1-(naphthalene-2-yl)propyl-2-en-1-ol, 1-(anthracen-2-yl)propyl-2-en-1-ol (E)-3-(4-((trimethylsilyl)ethynyl)phenyl)propyl-2-en-1-ol, (E)-5,9-dimethyldeca-2,8-dien-1-ol, (E)-3-(3-phenoxyphenyl)propyl-2-en-1-ol, (E)-2-bromopropane-3-phenylpropyl-2-en-1-ol, (E)- 3-phenylbutyl-2-en-1-ol, (E)-2-methyl-3-phenylprop-2-en-1-ol, (E)-3-cyclohexylprop-2-en-1-ol, (E)-5,9-dimethyldeca-1,8-dien-3-ol, (2E, 4E)-5-phenyl-2,4-pentadien-1-ol, (E)-4-phenyl-3-buten-2-ol, (E)-3-(2-methoxyphenyl)propyl-2-en-1-ol, (E)-3-methylprop-2-en-1-ol.
优选地,在步骤(1)中,在40℃温度下搅拌反应10h。Preferably, in step (1), the reaction is stirred at 40° C. for 10 h.
优选地,在步骤(2)中,所述除去溶剂为通过真空旋转蒸发器除去反应溶剂,所述纯化为通过薄层层析法/柱层析法纯化,展开剂体系为石油醚/乙酸乙酯=5/1。Preferably, in step (2), the solvent removal is to remove the reaction solvent by a vacuum rotary evaporator, the purification is to purify by thin layer chromatography/column chromatography, and the developing solvent system is petroleum ether/ethyl acetate = 5/1.
本发明克服现有技术的不足,提供一种烯丙基砜类化合物的制备方法,包括以下步骤:The present invention overcomes the deficiencies of the prior art and provides a method for preparing an allyl sulfone compound, comprising the following steps:
(1)在惰性气体氛围下,将亚磺酸和烯丙醇加入反应溶剂中,在20~60℃条件下搅拌反应8~36h。其反应的化学方程式为:(1) In an inert gas atmosphere, sulfinic acid and allyl alcohol are added to a reaction solvent and stirred at 20 to 60° C. for 8 to 36 hours. The chemical equation of the reaction is:
该反应式中,化合物1是烯丙醇,其中,R1选自烷基(C1-C15的链烷基或环烷基)、正芳基(苯环上带有甲基、甲氧基、氰基、硝基、叔丁基、氟基、三氟甲基、氯基、溴基、二茂铁基、乙炔基、三甲基硅烷乙炔基)、稠环芳基(萘、蒽)、杂芳基(呋喃、吲哚、吡啶、噻吩)基中的任意一种;In the reaction formula, compound 1 is allyl alcohol, wherein R 1 is selected from any one of alkyl (C1-C15 chain alkyl or cycloalkyl), n-aryl (methyl, methoxy, cyano, nitro, tert-butyl, fluoro, trifluoromethyl, chloro, bromo, ferrocenyl, ethynyl, trimethylsilaneethynyl on the benzene ring), condensed ring aryl (naphthalene, anthracene), and heteroaryl (furan, indole, pyridine, thiophene) groups;
化合物2是亚磺酸,R2选自烷基(C1~C15的链烷基或环烷基)、正芳基(苯环上带有甲基、甲氧基、氰基、硝基、叔丁基、氟基、三氟甲基、氯基、溴基、二茂铁基、乙炔基、三甲基硅烷乙炔基)、稠环芳基(萘、蒽)、杂芳基(呋喃、吲哚、吡啶、噻吩)基中的任意一种;Compound 2 is sulfinic acid, R 2 is selected from any one of alkyl (C1-C15 chain alkyl or cycloalkyl), n-aryl (methyl, methoxy, cyano, nitro, tert-butyl, fluoro, trifluoromethyl, chloro, bromo, ferrocenyl, ethynyl, trimethylsilaneethynyl on the benzene ring), condensed ring aryl (naphthalene, anthracene), heteroaryl (furan, indole, pyridine, thiophene) groups;
(2)除去步骤(1)所得反应液的反应溶剂,再通过薄层层析法/柱层析法纯化,得到烯丙基砜类化合物。(2) removing the reaction solvent from the reaction solution obtained in step (1), and purifying the solution by thin layer chromatography/column chromatography to obtain an allyl sulfone compound.
本发明制备方法中,在无金属催化的条件下通过烯丙基醇与亚磺酸直接脱水交叉偶联合成烯丙基砜,从而使反应在温和条件下以环境友好的方式发生。In the preparation method of the present invention, allyl sulfone is synthesized by direct dehydration cross coupling of allyl alcohol and sulfinic acid under the condition of no metal catalysis, so that the reaction occurs in an environmentally friendly manner under mild conditions.
相比于现有技术的缺点和不足,本发明具有以下有益效果:本发明制备方法中所用的烯丙醇为合成简单、转化率较好的烯丙醇,适用的底物范围广泛,如烯丙醇上可以是各种取代苯基、烷基,具有制备成本低的特点;此外,本发明制备方法步骤简单、操作方便、产物产率高,并且所得副产物只有水,还具有原子经济性高、绿色环保的特点;而且本发明制备方法无需使用任何催化剂和配体,对精细化学和工业生产具有潜在的应用价值;所得烯丙基砜类化合物可利用其烯丙基和砜基部分从而作为有机合成砌块进行各种衍生化,还是在天然产物、生物和药物分子中广泛存在的重要骨架,具有潜在的生物活性和药物活性。Compared with the shortcomings and deficiencies of the prior art, the present invention has the following beneficial effects: the allyl alcohol used in the preparation method of the present invention is an allyl alcohol with simple synthesis and good conversion rate, and has a wide range of applicable substrates, such as various substituted phenyl groups and alkyl groups on the allyl alcohol, and has the characteristics of low preparation cost; in addition, the preparation method of the present invention has simple steps, convenient operation, high product yield, and only water as the by-product, and has the characteristics of high atom economy and green environmental protection; and the preparation method of the present invention does not need to use any catalyst and ligand, and has potential application value in fine chemistry and industrial production; the obtained allyl sulfone compound can be used as an organic synthesis building block to carry out various derivatizations by utilizing its allyl and sulfone moieties, and is also an important skeleton widely present in natural products, biological and drug molecules, and has potential biological activity and drug activity.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1是本发明实施例1中化合物3的核磁共振氢谱图;FIG1 is a hydrogen nuclear magnetic resonance spectrum of compound 3 in Example 1 of the present invention;
图2是本发明实施例1中化合物3的核磁共振碳谱图;FIG2 is a carbon NMR spectrum of compound 3 in Example 1 of the present invention;
图3是本发明实施例2中化合物5的核磁共振氢谱图;FIG3 is a hydrogen nuclear magnetic resonance spectrum of compound 5 in Example 2 of the present invention;
图4是本发明实施例2中化合物5的核磁共振碳谱图;FIG4 is a carbon NMR spectrum of compound 5 in Example 2 of the present invention;
图5是本发明实施例4中化合物9的核磁共振氢谱图;FIG5 is a hydrogen nuclear magnetic resonance spectrum of compound 9 in Example 4 of the present invention;
图6是本发明实施例4中化合物9的核磁共振碳谱图;FIG6 is a carbon NMR spectrum of compound 9 in Example 4 of the present invention;
图7是本发明实施例5中化合物11的核磁共振氢谱图;FIG7 is a hydrogen nuclear magnetic resonance spectrum of compound 11 in Example 5 of the present invention;
图8是本发明实施例5中化合物11的核磁共振碳谱图。FIG8 is a carbon NMR spectrum of compound 11 in Example 5 of the present invention.
具体实施方式DETAILED DESCRIPTION
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合附图及实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not intended to limit the present invention.
实施例1Example 1
(1)在10mL史莱克管中,在氮气环境下,将0.3mmol(E)-3-苯基丙-2-烯-1-醇、0.9mmol苯亚磺酸加入到3mL的二氯甲烷中,在40℃下搅拌反应10h,反应方程式为:(1) In a 10 mL Shrek tube, under nitrogen atmosphere, 0.3 mmol (E)-3-phenylprop-2-en-1-ol and 0.9 mmol benzenesulfinic acid were added to 3 mL of dichloromethane and stirred at 40° C. for 10 h. The reaction equation is:
(2)TLC监测反应完全后,用真空旋转蒸发器除去溶剂,薄层层析法分离产物,展开剂为石油醚/乙酸乙酯体系(5/1),产物为淡黄色固体化合物3,收率82%。(2) After the reaction was completed as monitored by TLC, the solvent was removed by vacuum rotary evaporator and the product was separated by thin layer chromatography. The developing solvent was petroleum ether/ethyl acetate system (5/1). The product was a light yellow solid compound 3 with a yield of 82%.
对化合物3进行表征,核磁谱图如图1~2所示,具体为:Compound 3 was characterized, and its NMR spectra are shown in Figures 1 and 2, specifically:
1H NMR(400MHz,Chloroform-d)δ7.83-7.78(m,2H),7.59-7.53(m,1H),7.48-7.43(m,1H),7.26-7.16(m,5H),6.29(dt,J=15.8,1.3Hz,1H),6.07-5.97(m,1H),3.88(dd,J=7.6,1.2Hz,2H).13C NMR(100MHz,Chloroform-d)δ139.33,138.43,135.83,133.91,129.22,128.78,128.63,126.72,115.18,60.58,29.80.IR(KBr):3056,2919,1647,1317,1135,749cm-1.HRMS(ESI/[M+H]+)Calcd.for:C15H15O2S259.0793,found 259.0790。 1 H NMR (400MHz, Chloroform-d) δ7.83-7.78(m,2H),7.59-7.53(m,1H),7.48-7.43(m,1H),7.26-7.16(m,5H),6.29( dt,J=15.8,1.3Hz,1H),6.07-5.97(m,1H),3.88(dd,J=7.6,1.2Hz,2H). 13 C NMR(100MHz,Chloroform-d)δ139.33,138.43,135.83,133.91,129.22,128.78,128.63,126.72,115.18,60.58,29.80.IR(KBr):3056,2919,1647,1317,1135, 749cm -1 .HRMS (ESI/[M+H] + )Calcd.for:C 15 H 15 O 2 S259.0793, found 259.0790.
表征结果表明,化合物3为(肉桂基磺酰基)苯。The characterization results showed that compound 3 was (cinnamylsulfonyl)benzene.
实施例2Example 2
(1)在10mL史莱克管中,在氮气环境下,将0.3mmol(E)-3-苯基丙-2-烯-1-醇、0.9mmol 4-甲基苯亚磺酸加入到3mL的二氯甲烷中,在40℃下搅拌反应15h,反应方程式为:(1) In a 10 mL Shrek tube, under nitrogen atmosphere, 0.3 mmol (E)-3-phenylprop-2-en-1-ol and 0.9 mmol 4-methylbenzenesulfinic acid were added to 3 mL of dichloromethane and stirred at 40° C. for 15 h. The reaction equation is:
(2)TLC监测反应完全后,用真空旋转蒸发器除去溶剂,薄层层析法分离产物,展开剂为石油醚/乙酸乙酯体系(5/1),产物为淡黄色固体化合物5,收率75%。(2) After the reaction was completed as monitored by TLC, the solvent was removed by vacuum rotary evaporator and the product was separated by thin layer chromatography. The developing solvent was petroleum ether/ethyl acetate system (5/1). The product was a light yellow solid compound 5 with a yield of 75%.
对化合物5进行表征,核磁谱图如图3~4所示,具体为:Compound 5 was characterized, and its NMR spectra are shown in Figures 3 and 4, specifically:
1H NMR(400MHz,Chloroform-d)δ7.78-7.73(m,2H),7.34-7.26(m,7H),6.38(dt,J=15.9,4.0Hz,1H),6.14-6.05(m,1H),3.93(dd,J=7.6,1.2Hz,2H),2.42(s,3H).13C NMR(100MHz,Chloroform-d)δ144.85,139.09,135.92,135.62,129.82,128.74,128.59,128.55,126.71,115.43,60.63,21.73.IR(KBr):3023,2921,1649,1314,1149,814cm-1.HRMS(ESI/[M+H]+)Calcd.for:C16H17O2S273.0949,found 273.0943。 1 H NMR (400MHz, Chloroform-d) δ7.78-7.73 (m, 2H), 7.34-7.26 (m, 7H), 6.38 (dt, J = 15.9, 4.0Hz, 1H), 6.14-6.05 (m, 1H),3.93(dd,J=7.6,1.2Hz,2H),2.42(s,3H). 13 C NMR(100MHz,Chloroform-d)δ144.85,139.09,135.92,135.62,129.82,128.74,128.59,128.55,126.71,115.43,60.63,21.73.IR(KBr):3023,2921,1649,131 4,1149,814cm -1 .HRMS(ESI/[M+H] + )Calcd.for:C 16 H 17 O 2 S273.0949,found 273.0943.
表征结果表明,化合物5为1-(肉桂基磺酰基)-4-甲基苯。The characterization results showed that compound 5 was 1-(cinnamylsulfonyl)-4-methylbenzene.
实施例3Example 3
(1)在10mL史莱克管中,在氮气环境下,将0.3mmol(E)-3-苯基丙-2-烯-1-醇、0.9mmol 4-甲氧基苯亚磺酸加入到3mL的二氯甲烷中,在40℃下搅拌反应10h,反应方程式为:(1) In a 10 mL Shrek tube, under nitrogen atmosphere, 0.3 mmol (E)-3-phenylprop-2-en-1-ol and 0.9 mmol 4-methoxybenzenesulfinic acid were added to 3 mL of dichloromethane and stirred at 40° C. for 10 h. The reaction equation is:
(2)TLC监测反应完全后,用真空旋转蒸发器除去溶剂,薄层层析法分离产物,展开剂为石油醚/乙酸乙酯体系(5/1),产物为淡黄色固体化合物7,收率69%。(2) After the reaction was completed as monitored by TLC, the solvent was removed by vacuum rotary evaporator and the product was separated by thin layer chromatography. The developing solvent was petroleum ether/ethyl acetate system (5/1). The product was a light yellow solid compound 7 with a yield of 69%.
对化合物7进行表征,具体为:Compound 7 was characterized as follows:
1H NMR(400MHz,Chloroform-d)δ7.82-7.77(m,2H),7.34-7.26(m,5H),7.01-6.95(m,2H),6.38(d,J=15.9Hz,1H),6.16-6.06(m,1H),3.93(dd,J=7.5,1.3Hz,2H),3.86(s,3H).13C NMR(100MHz,Chloroform-d)δ163.82,139.01,135.87,130.74,129.96,128.73,128.54,126.68,115.56,114.33,60.77,55.75.IR(KBr):3013,2921,1648,1317,1087,759cm-1.HRMS(ESI/[M+H]+)Calcd.for:C16H17O3S289.0898,found 289.0892。 1 H NMR (400MHz, Chloroform-d) δ7.82-7.77(m,2H),7.34-7.26(m,5H),7.01-6.95(m,2H),6.38(d,J=15.9Hz,1H) ,6.16-6.06(m,1H),3.93(dd,J=7.5,1.3Hz,2H),3.86(s,3H). 13 C NMR(100MHz,Chloroform-d)δ163.82,139.01,135.87,130.74,129.96,128.73,128.54,126.68,115.56,114.33,60.77,55.75.IR(KBr):3013,2921,1648,131 7,1087,759cm -1 .HRMS(ESI/[M+H] + )Calcd.for:C 16 H 17 O 3 S289.0898, found 289.0892.
表征结果表明,化合物7为1-(肉桂基磺酰基)-4-甲氧基苯。The characterization results showed that compound 7 was 1-(cinnamylsulfonyl)-4-methoxybenzene.
实施例4Example 4
(1)在10mL史莱克管中,在氮气环境下,将0.3mmol(E)-3-环己基丙-2-烯-1-醇、0.9mmol苯亚磺酸加入到3mL的二氯甲烷中,在40℃下搅拌反应18h,反应方程式为:(1) In a 10 mL Shrek tube, under nitrogen atmosphere, 0.3 mmol (E)-3-cyclohexylprop-2-en-1-ol and 0.9 mmol benzenesulfinic acid were added to 3 mL of dichloromethane and stirred at 40° C. for 18 h. The reaction equation is:
(2)TLC监测反应完全后,用真空旋转蒸发器除去溶剂,薄层层析法分离产物,展开剂为石油醚/乙酸乙酯体系(5/1),产物为淡黄色液体化合物9,收率48%。(2) After the reaction was completed as monitored by TLC, the solvent was removed by vacuum rotary evaporator and the product was separated by thin layer chromatography. The developing solvent was petroleum ether/ethyl acetate system (5/1). The product was a light yellow liquid compound 9 with a yield of 48%.
对化合物9进行表征,磁谱图如图5~6所示,具体为:Compound 9 was characterized, and its magnetic spectra are shown in Figures 5 and 6, specifically:
1H NMR(400MHz,Chloroform-d)δ7.84(m,2H),7.64(td,J=7.1,3.3Hz,1H),7.54(t,J=7.7Hz,2H),5.41-5.30(m,2H),3.78-3.69(m,2H),1.96-1.85(m,1H),1.70-1.52(m,5H),1.38-1.03(m,3H),0.98-0.85(m,2H).13C NMR(100MHz,Chloroform-d)δ147.41,138.14,133.68,128.98,128.74,113.77,60.32,40.75,32.29,26.02,25.80.IR(KBr):3064,2924,1661,1446,1318,748cm-1.HRMS(ESI/[M+H]+)Calcd.for:C15H21O2S265.1262,found 265.1256。 1 H NMR (400MHz, Chloroform-d) δ7.84 (m, 2H), 7.64 (td, J = 7.1, 3.3Hz, 1H), 7.54 (t, J = 7.7Hz, 2H), 5.41-5.30 (m 13 C NMR(100MHz,Chloroform-d)δ147.41,138.14,133.68,128.98,128.74,113.77,60.32,40.75,32.29,26.02,25.80.IR(KBr):3064,2924,1661,1446,1318,748cm -1.HRMS (ESI/[M+H] + )Calcd.for:C 15 H 21 O 2 S265.1262, found 265.1256.
核表征结果表明,化合物9为(E)-((3-环己基烯丙基)磺酰)苯。Nuclear characterization results showed that compound 9 was (E)-((3-cyclohexylallyl)sulfonyl)benzene.
实施例5Example 5
(1)在10mL史莱克管中,在氮气环境下,将0.3mmol 5,9-二甲基十-1,8-二烯-3-醇、1.2mmol苯亚磺酸加入到3mL的二氯甲烷中,在40℃下搅拌反应24h,反应方程式为:(1) In a 10 mL Shrek tube, under nitrogen atmosphere, 0.3 mmol 5,9-dimethyldeca-1,8-dien-3-ol and 1.2 mmol benzenesulfinic acid were added to 3 mL dichloromethane and stirred at 40°C for 24 h. The reaction equation is:
(2)TLC监测反应完全后,用真空旋转蒸发器除去溶剂,薄层层析法分离产物,展开剂为石油醚/乙酸乙酯体系(10/1),产物为淡黄色液体化合物11,收率43%。(2) After the reaction was completed as monitored by TLC, the solvent was removed by a vacuum rotary evaporator and the product was separated by thin layer chromatography using a petroleum ether/ethyl acetate system (10/1) as the developing solvent. The product was a light yellow liquid compound 11 with a yield of 43%.
对化合物11进行表征,核磁谱图如图7~8所示,具体为:Compound 11 was characterized, and its NMR spectra are shown in Figures 7 and 8, specifically:
1H NMR(400MHz,Chloroform-d)δ7.86(dq,J=8.4,1.5Hz,2H),7.67-7.61(m,1H),7.59-7.50(m,2H),5.56-5.45(m,1H),5.43-5.30(m,1H),5.10-5.00(m,1H),3.77(d,J=7.1Hz,2H),2.09-1.77(m,4H),1.68(s,3H),1.60(d,J=12.7Hz,3H),1.49-1.32(m,1H),1.28-1.16(m,1H),1.12-0.97(m,1H),0.75(d,J=6.6Hz,3H).13C NMR(100MHz,Chloroform-d)δ140.59,138.42,133.72,131.45,129.14,128.59,124.66,117.10,60.30,40.04,36.58,32.39,25.87,25.56,19.34,17.79.IR(KBr):3063,2961,2920,2854,1664,1319,764cm- 1.HRMS(ESI/[M+H]+)Calcd.for:C18H27O2S 307.1732,found 307.1723。 1 H NMR (400MHz, Chloroform-d) δ7.86 (dq, J=8.4, 1.5Hz, 2H), 7.67-7.61 (m, 1H), 7.59-7.50 (m, 2H), 5.56-5.45 (m, 1H),5.43-5.30(m,1H),5.10-5.00(m,1H),3.77(d,J=7.1Hz,2H),2.09-1.77(m,4H),1.68(s,3H),1.60 (d,J=12.7Hz,3H),1.49-1.32(m,1H),1.28-1.16(m,1H),1.12-0.97(m,1H),0.75(d,J=6.6Hz,3H). 13C NMR(100MHz,Chloroform-d)δ140.59,138.42,133.72,131.45,129.14,128.59,124.66,117.10,60.30,40.04,36.58,32.39,25.87,25.56,19.34,17.79.IR( KBr):3063,2961,2920 ,2854,1664,1319,764cm - 1 .HRMS(ESI/[M+H] + )Calcd.for:C 18 H 27 O 2 S 307.1732, found 307.1723.
表征结果表明,化合物11为(E)-(5,9-二甲基十-2,8-二烯-1-基)磺酰基)苯。The characterization results showed that compound 11 was (E)-(5,9-dimethyldeca-2,8-dien-1-yl)sulfonyl)benzene.
实施例6Example 6
该实施例6与实施例1基本相同,差别之处在于步骤(1):在250mL史莱克管中,在氮气环境下,将7.5mmol(E)-3-苯基丙-2-烯-1-醇、22.5mmol苯亚磺酸加入到75mL二氯甲烷中,在40℃下搅拌反应12h,所得产物收率为81%。This Example 6 is basically the same as Example 1, except for step (1): in a 250 mL Shrek tube, under a nitrogen environment, 7.5 mmol (E)-3-phenylprop-2-en-1-ol and 22.5 mmol benzenesulfinic acid were added to 75 mL dichloromethane, and the reaction was stirred at 40° C. for 12 h. The yield of the obtained product was 81%.
实施例7~14Embodiments 7 to 14
实施例7~14与实施例1基本相同,差别之处下表1所示:Examples 7 to 14 are substantially the same as Example 1, except that the differences are shown in Table 1 below:
表1差别比较Table 1 Comparison of differences
实施例15~20Examples 15 to 20
实施例15~20与实施例1基本相同,差别之处下表2所示:Examples 15 to 20 are substantially the same as Example 1, except that the differences are shown in Table 2 below:
表2差别比较Table 2 Comparison of differences
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等,均应包含在本发明的保护范围之内。The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311105963.3A CN117142916B (en) | 2023-08-30 | 2023-08-30 | Preparation method of allyl sulfone compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311105963.3A CN117142916B (en) | 2023-08-30 | 2023-08-30 | Preparation method of allyl sulfone compound |
Publications (2)
Publication Number | Publication Date |
---|---|
CN117142916A CN117142916A (en) | 2023-12-01 |
CN117142916B true CN117142916B (en) | 2024-10-11 |
Family
ID=88900040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311105963.3A Active CN117142916B (en) | 2023-08-30 | 2023-08-30 | Preparation method of allyl sulfone compound |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117142916B (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110627693B (en) * | 2019-10-16 | 2021-06-04 | 南京工业大学 | Allyl sulfone compound and preparation method and application thereof |
PL243187B1 (en) * | 2020-07-16 | 2023-07-10 | Vitasynth Spolka Z Ograniczona Odpowiedzialnoscia | Method and intermediates for preparation of menaquinone MK-7 |
-
2023
- 2023-08-30 CN CN202311105963.3A patent/CN117142916B/en active Active
Non-Patent Citations (1)
Title |
---|
Sulfination of Unactivated Allylic Alcohols via Sulfinate-Sulfone Rearrangement;Wang, Yan 等;《Organic Letters》;20231207;第25卷(第49期);8895-8900页 * |
Also Published As
Publication number | Publication date |
---|---|
CN117142916A (en) | 2023-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114874126B (en) | Synthetic method of 3-bromoindole compound | |
CN101219399A (en) | Preparation method and application of nitrogen heterocyclic carbene metal palladium catalyst | |
CN111875515A (en) | Method for generating amide by catalyzing primary amine with metal complex | |
CN114560802B (en) | Method for constructing carbon-nitrogen axis chiral indole-naphthol biaryl compound | |
CN110003011B (en) | A kind of preparation method of nitroalkene derivative with nitrate as nitro source | |
CN117142916B (en) | Preparation method of allyl sulfone compound | |
CN110683926B (en) | Preparation method of carboxylic acid aryl ester compound | |
CN108084050A (en) | A kind of aluminium phosphate molecular sieve is catalyzed imines synthetic method | |
CN113248458B (en) | A kind of preparation method of α-carbonyl amide compound | |
CN109942361A (en) | A kind of preparation method of aryl-substituted triphenylene compound and application thereof | |
CN105237466B (en) | A kind of method for synthesizing three substituted pyridine derivatives | |
CN116162027A (en) | A method for the synthesis of α,β-unsaturated ketones by iron-catalyzed carbonylation three-component coupling reaction | |
CN115611693A (en) | A method for catalytically synthesizing isochroman-1-ketones or aromatic ketones | |
CN107629049A (en) | A kind of pyridine [2,1 a] and the synthetic method of isoindoles compound | |
CN114835713A (en) | Synthesis method of 7-methylpyrazolopyrimidine compound | |
CN107344904A (en) | A kind of method of palladium chtalyst oxyalkylene generation MIBK | |
CN107469858B (en) | A chiral diamine-derived thiourea catalyst supported by pentaerythritol and its preparation method and application | |
CN104529684A (en) | Method for iodization of ortho-position of functional group on palladium/carbon catalytic aromatic ring | |
CN100491387C (en) | Ferrocenyl imidazoline ring palladium compound, its preparation and its application in catalytic synthesis of coupled products | |
CN116462598B (en) | Allyl arylamine compound and preparation method and application thereof | |
CN113429323B (en) | Preparation method of sulfonyl substituted styrene type axial chiral compound | |
CN112574164B (en) | A method for the synthesis of chiral spiro molecules based on chiral binaphthol | |
CN113403635B (en) | A kind of method for preparing N-substituted pyrrolidone derivatives | |
CN112225685B (en) | 3-cyanoindole compound, preparation method and application thereof | |
CN116514679A (en) | Palladium-catalyzed sp with low-cost and high-efficiency quaternary ammonium nitrate as oxidant 2 And sp (sp) 3 Carbon hydrogen bond alkenylation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |